Immunohistochemical study on the distribution of alpha-synuclein in the central nervous system of transgenic mice expressing a human Cu/Zn superoxide dismutase mutation
Section snippets
Acknowledgements
This study was supported by a grant of the Biomedical Brain Research Center Grant, Ministry of Health and Welfare, Republic of Korea (01-PJ8-PG6-01NE01-0003). This study was supported in part by year 2003 BK21 project for Medicine, Dentistry and Pharmacy.
References (17)
- et al.
Immunocytochemical study on the distribution of nitrotyrosine in the brain of the transgenic mice expressing a human Cu/Zn SOD mutation
Brain Res.
(2000) - et al.
Hydrogen peroxide-mediated Cu,Zn-superoxide dismutase fragmentation: protection by carnosine, homocarnosine, and anserine
Biochim. Biophys. Acta
(1999) - et al.
Fragmentation of human Cu,Zn-superoxide dismutase by peroxidative reaction
Mol. Cells
(1997) - et al.
Aggregation of alpha-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system
Free Radic. Biol. Med.
(2002) - et al.
Immunohistochemical study on the distribution of Bcl-2 and Bax in the central nervous system of the transgenic mice expressing a human Cu/Zn SOD mutation
Brain Res.
(2000) - et al.
Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
Neurosci. Lett.
(1998) - et al.
Enzyme function of copper, zinc superoxide dismutase as a free radical generator
J. Biol. Chem.
(1993) - et al.
A familial amyotrophic lateral sclerosis-associated A4V Cu, Zn-superoxide dismutase mutant has a lower Km for hydrogen peroxide. Correlation between clinical severity and the Km value
J. Biol. Chem.
(1997)
Cited by (15)
Ascending neuropathology in the CNS of a mutant SOD1 mouse model of amyotrophic lateral sclerosis
2006, Brain ResearchCitation Excerpt :Recent studies indicate that similar to the patients (DePaul et al., 1988; Desai and Swash, 1999; Kiernan and Hudson, 1991; Lloyd et al., 2000; Okamoto et al., 1993; Oyanagi et al., 1997) the neurodegenerative changes in SOD1-G93A transgenics are not confined to LMNs. Thus, cell loss was found in cranial motoneurons (Angenstein et al., 2004; Haenggeli and Kato, 2002; Zang et al., 2004) and in the substantia nigra (Kostic et al., 1997), while deleterious metabolic changes were shown in the hippocampus (Cha et al., 2000), the red nucleus (Chung et al., 2003b), the cerebellum (Cha et al., 2000; Chung et al., 2003b, 2004) and the cortex (Chung et al., 2003a; Holasek et al., 2005; Li et al., 2004; Zang et al., 2004). Since these previous studies focused either on a distinct CNS region or on a certain age of the transgenics, they could not monitor the progression of the disease.
Neuronal inclusions in sporadic motor neuron disease are negative for alpha-synuclein
2006, Neuroscience LettersSecondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
2023, Frontiers in Bioscience - LandmarkMolecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis
2023, International Journal of Molecular Sciences